BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21106578)

  • 1. Temporary external implantable cardioverter defibrillator in the pacemaker-dependent ventricular tachycardia patient.
    Cooper JM; Lavi N; Polin GM; Dixit S; Verdino RJ
    Europace; 2011 May; 13(5):761-3. PubMed ID: 21106578
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Van Gelder BM; Meijer A; Dekker LR; Bracke FA
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An appropriate implantable cardioverter-defibrillator shock triggering unusual phenomenons.
    Arias MA; Puchol A; Colchero T; Pachón M; Castellanos E; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1157-60. PubMed ID: 20487346
    [No Abstract]   [Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator oversensing: what is the mechanism?
    Vijayaraman P; Ferrell MS; Rhee B; Elam G; Kok LC
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):723-4. PubMed ID: 15175071
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed termination of ventricular tachycardia after cardioversion.
    Stiles MK; Lau DH; Young GD; Sanders P
    Europace; 2007 Sep; 9(9):730-1. PubMed ID: 17639067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead system causing twiddler's syndrome in patients with an implantable cardioverter-defibrillator.
    Bracke F; van Gelder B; Dijkman B; Meijer A
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):231-2. PubMed ID: 15632856
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pacemaker and implantable cardioverter defibrillator infections].
    Camus C; Donal E; Bodi S; Tattevin P
    Med Mal Infect; 2010 Aug; 40(8):429-39. PubMed ID: 20044226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillator infection due to Scedosporium apiospermum.
    Sarvat B; Sarria JC
    J Infect; 2007 Oct; 55(4):e109-13. PubMed ID: 17761293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of ventricular tachyarrhythmias with an implantable pacemaker-cardioverter-defibrillator].
    Ohm OJ; Faerestrand S; Engedal H; Hegbom F; Stangeland L; Hoff PI
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):182-9. PubMed ID: 8430397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed detection of stable ventricular tachycardia in a dual-chamber implantable cardioverter defibrillator: what is the mechanism?
    Strohmer B; Schernthaner C; Pichler M
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):244-6. PubMed ID: 15028059
    [No Abstract]   [Full Text] [Related]  

  • 12. Perforation of the right ventricular free wall by an ICD lead in a patient with isolated noncompaction of the ventricular myocardium.
    Sakai Y; Sato Y; Matsuo S; Imai S; Kunimasa T; Matsumoto N; Saito S
    Int J Cardiol; 2007 May; 117(3):e104-6. PubMed ID: 17350119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyoplasty after implantation of a pacemaker and cardioverter/defibrillator.
    Chekanov VS; Deshpande S; Francischelli D; Werner P; Waller D; Schmidt DH
    Ann Thorac Surg; 1998 Sep; 66(3):954-6. PubMed ID: 9768969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular oversensing after replacement of an implantable cardioverter-defibrillator.
    Arias MA; Puchol A; Castellanos E; Pachón M; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):925-7. PubMed ID: 19572871
    [No Abstract]   [Full Text] [Related]  

  • 15. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.
    Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Stoner S; Baddour LM
    J Am Coll Cardiol; 2007 May; 49(18):1851-9. PubMed ID: 17481444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive treatment can beat infections in implantable devices. When "vegetation" invades a pacemaker or cardioverter-defibrillator, your life could depend on its prompt removal.
    Heart Advis; 2002 Mar; 5(3):4-5. PubMed ID: 16144081
    [No Abstract]   [Full Text] [Related]  

  • 19. Large septic pulmonary embolism complicating extraction of an infected transvenous defibrillator lead.
    Pai RK; Macgregor JF; Lund JF; Freedman RA
    Heart Rhythm; 2006 Apr; 3(4):496-7. PubMed ID: 16567305
    [No Abstract]   [Full Text] [Related]  

  • 20. Phantom shock in a patient with an implantable cardioverter defibrillator: case report.
    Prudente LA
    Am J Crit Care; 2003 Mar; 12(2):144-6. PubMed ID: 12625172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.